Search

everythinglearnresearchcommunity

for

Search:↓

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

Certain genetic markers may increase or decrease prostate cancer risk.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

TAZ boosts fat cell formation in goat stem cells by activating a specific signaling pathway.

Krt15+ cells in mice can resist radiation, regenerate tissue, and start tumors, suggesting new cancer treatment targets.

Different harmful mutations in the CDH3 gene cause HJMD, but symptoms vary among individuals.

An elderly woman's upper lip lump, thought to be a mucocele, was actually a rare type of lymphoma usually found on legs, treated successfully with chemotherapy and radiation.

CXCL7 is essential for muscle repair by aiding early neutrophil infiltration.

CXCR2 in skin cells promotes tumor growth.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Lack of functional CYLD in mice leads to early aging and cancer.

Cancer-associated fibroblasts promote tumor growth in skin cancer.

Targeting ornithine decarboxylase can help prevent skin cancer.

Cadd4 effectively reduces cholesterol levels without side effects.

Feline cutaneous lymphocytosis is likely reactive, while canine cutaneous lymphocytosis needs more study to understand its nature.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

K6/ODC transgenic mice are effective for quickly identifying cancer-causing chemicals.

A specific RNA, circNlgn, contributes to heart damage and scarring caused by the cancer drug doxorubicin.

Topical IKKα inhibitors may help prevent CCS tumours.

The enzyme CD73 helps control human hair growth and could be targeted to treat hair growth disorders.

A specific gene mutation causes hair loss and potential eye issues, even if vision seems normal.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

The protein CCN2 controls hair growth by affecting hair follicle formation and stem cell activity in mice.

The assay effectively identifies compounds that affect immune cell activation.

People with Alopecia areata have higher levels of certain T regulatory cells in their blood.

Targeting specific T cells may help treat alopecia areata.